NCT00433589View on ClinicalTrials.gov

Genetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Breast Cancer That Involves No More Than 3 Lymph Nodes

PHASE3CompletedINTERVENTIONAL
Enrollment

6,600

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

March 31, 2020

Study Completion Date

March 31, 2020

Conditions
Breast Cancer
Interventions
DRUG

anthracycline-based

DRUG

docetaxel and capecitabine

DRUG

tamoxifen

DRUG

Letrozole

Trial Locations (1)

Unknown

Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam

Sponsors
All Listed Sponsors
collaborator

Agendia

INDUSTRY

collaborator

Breast International Group

OTHER

collaborator

Roche Pharma AG

INDUSTRY

collaborator

Novartis

INDUSTRY

collaborator

Sanofi

INDUSTRY

lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK